Financing ·
Enlivex Ltd. amended its Senior Secured Convertible Promissory Note with Lind Global Asset Management XIV, LLC on…
ENLVEnlivex Ltd.
Enlivex Ltd. amended its Senior Secured Convertible Promissory Note with Lind Global Asset Management XIV, LLC on August 11, 2026. The amendment waived a prior event of default related to market capitalization and increased the outstanding principal balance from approximately $16.3 million to $19.2 million. Monthly repayment obligations were reduced from approximately $2.3 million to $1.2 million, with maturity extended until full repayment. The conversion price was revised to the lower of $40.37625 or 80% of the average of the three lowest daily volume-weighted average prices over the preceding 20 trading days. A 10% interest rate applies if market capitalization remains below $75 million, and a reduced prepayment premium of 2.5% is available for six months. Enlivex Ltd. operates in the biotechnology industry, developing targeted therapies for cancer treatment.